EverSource Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Sell |
649
-212
| -25% | -$3.55K | ﹤0.01% | 2747 |
|
|
2025
Q1 | $13.2K | Sell |
861
-8,304
| -91% | -$128K | ﹤0.01% | 1944 |
|
|
2024
Q4 | $202K | Buy |
9,165
+8,542
| +1,371% | +$188K | 0.01% | 651 |
|
|
2024
Q3 | $11.2K | Hold |
623
| – | – | ﹤0.01% | 1797 |
|
|
2024
Q2 | $10.9K | Sell |
623
-518
| -45% | -$9.03K | ﹤0.01% | 1808 |
|
|
2024
Q1 | $16K | Sell |
1,141
-4,500
| -80% | -$63.2K | ﹤0.01% | 1469 |
|
|
2023
Q4 | $58.9K | Sell |
5,641
-2,500
| -31% | -$26.1K | 0.01% | 834 |
|
|
2023
Q3 | $83K | Sell |
8,141
-749
| -8% | -$7.64K | 0.01% | 638 |
|
|
2023
Q2 | $66.9K | Sell |
8,890
-3,341
| -27% | -$25.2K | 0.01% | 723 |
|
|
2023
Q1 | $108K | Buy |
12,231
+449
| +4% | +$3.97K | 0.01% | 521 |
|
|
2022
Q4 | $107K | Buy |
11,782
+10,396
| +750% | +$94.8K | 0.02% | 486 |
|
|
2022
Q3 | $11K | Buy |
1,386
+887
| +178% | +$7.04K | ﹤0.01% | 1113 |
|
|
2022
Q2 | $3K | Hold |
499
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q1 | $5K | Buy |
499
+305
| +157% | +$3.06K | ﹤0.01% | 1292 |
|
|
2021
Q4 | $2K | Buy |
+194
| New | +$2K | ﹤0.01% | 1631 |
|